"/> R&D Systems™ Cynomolgus Monkey VSIG4 (XP_00559… | B-LABO France

R&D Systems™ Cynomolgus Monkey VSIG4 (XP_005593850) VersaClone cDNA

Réf. : BL-RE-099899Réf. fabricant : 18752308 10 μg
294,81 € HT

This shuttle vector contains the complete ORF for the gene of interest, along with a Kozak consensus sequence for optimal translation initiation. It is inserted NotI to AscI. The gene insert is flanked with convenient multiple cloning sites which can be used to easily cut and transfer the gene cassette into your desired expression vector.

Expression
VSIG4
Numéro d’adhésion
XP_005593850
Concentration
10 μg at 0.2 μg/μL
Formule
cDNA is provided in 10 mM Tris-Cl, pH 8.5
Type d’insert
1228 bp
Marque
R&D Systems

Caractéristiques principales

  • VSIG4 (V-set and immunoglobulin domain containing 4), also known as CRIg and Z39IG, is a 45 kDa, type I transmembrane protein of the B7 family within the Ig superfamily that is expressed only in tissue-resident macrophages.
  • The gene is located on the X chromosome.
  • The human VSIG4 cDNA encodes 399 amino acids (aa) including a 19 aa signal sequence, a 264 aa extracellular domain (ECD) containing a V-type and a C2-type Ig domain, a 21 aa transmembrane domain and a 95 aa cytoplasmic domain.
  • The human VSIG4 ECD shares 84% aa identity with canine VSIG4.
  • Within the IgV domain, it shares 90%, 80% and 78% aa identity with bovine, mouse and rat VSIG4, respectively; these animals lack the C2-type domain.
  • Splice isoforms of 321, 305, 272, 201 and 199 aa lack all or part of the cytoplasmic domain, the C2-type Ig domain and/or the transmembrane domain.
  • VSIG4 is specifically expressed on macrophages in the thymic medulla, peritoneum, alveoli, synovia, adipose and heart, liver Kupffer cells, placental Hofbauer cells, and atherosclerotic foam cells. It is absent on infiltrating macrophages.
  • VSIG4 is a complement receptor that binds C3b and iC3b fragments, internalizes them to recycling endosomes, and is recycled to the cell surface.
  • It contributes significantly to innate immunity by binding and phagocytosis of complement-opsonized invading pathogens.
  • Binding of either native or recombinant soluble VSIG4 to C3b inhibits complement amplification through the alternative, but not classical, pathway.
  • VSIG4 is also a negative regulator of mouse and human T cell activation.
  • Although VSIG4 engagement may activate NF-kappa-B and thus be pro-inflammatory in some cases, many of its activities are important in resolving, rather than initiating, inflammation.
  • The VSIG4 insert is sequence verified and the entire plasmid DNA and insert translated sequences are provided.
  • For reasearch use only. Not for use in humans.

Caractéristiques techniques

MarqueR&D Systems
Réf. B-LABOBL-RE-099899
Réf. fabricant18752308
ExpressionVSIG4
Numéro d’adhésionXP_005593850
Concentration10 μg at 0.2 μg/μL
FormulecDNA is provided in 10 mM Tris-Cl, pH 8.5
Type d’insert1228 bp
Identification génétique (Entrez)11326
Alias de gèneCRIg, Ig superfamily protein, Protein Z39Ig, V-set and immunoglobulin domain containing 4, V-set and immunoglobulin domain-containing protein 4, Z39IG, Z39IGcomplement receptor of the immunoglobulin superfamily
Contenu et stockageStore the unopened product at -20°C to -70°C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
EspècesCynomolgus Monkey
Quantité10 μg
Une question, une configuration particulière ?
Contactez-nous pour un devis.